Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001416083-14-000011
Filing Date
2014-04-23
Accepted
2014-04-23 13:52:42
Documents
12
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q catalent-2014331x10q.htm 10-Q 1909297
2 EXHIBIT catalent-20140331xex311.htm EX-31.1 8589
3 EXHIBIT catalent-20140331xex312.htm EX-31.2 8716
4 EXHIBIT catalent-20140331xex321.htm EX-32.1 5064
5 EXHIBIT catalent-20140331xex322.htm EX-32.2 4796
6 EXHIBIT catalent-20140331xex991.htm EX-99.1 4195
  Complete submission text file 0001416083-14-000011.txt   15464284

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ck0001416083-20140331.xml EX-101.INS 3313212
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ck0001416083-20140331.xsd EX-101.SCH 59783
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ck0001416083-20140331_cal.xml EX-101.CAL 109778
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ck0001416083-20140331_def.xml EX-101.DEF 196109
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ck0001416083-20140331_lab.xml EX-101.LAB 587871
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ck0001416083-20140331_pre.xml EX-101.PRE 377656
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent Pharma Solutions, Inc. (Filer) CIK: 0001416083 (see all company filings)

EIN.: 133523163 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-147871 | Film No.: 14778347
SIC: 2834 Pharmaceutical Preparations